株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

股関節再建:パイプライン分析

Hip Reconstruction - Medical Devices Pipeline Assessment, 2016

発行 GlobalData 商品コード 341587
出版日 ページ情報 英文 169 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
股関節再建:パイプライン分析 Hip Reconstruction - Medical Devices Pipeline Assessment, 2016
出版日: 2016年12月01日 ページ情報: 英文 169 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発が進められている股関節再建のパイプライン製品情報について分析しており、治験と製品開発の進行状況、段階別・セグメント別・国 (地域) 別の動向、企業と製品の詳細情報、最近の製品開発および業界の動向などの情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 股関節再建の概要

第3章 開発中の製品

  • 股関節再建 - 開発段階別のパイプライン製品
  • 股関節再建 - セグメント別のパイプライン製品
  • 股関節再建 - 国 (地域) 別のパイプライン製品
  • 股関節再建 - 規制別のパイプライン製品
  • 股関節再建 - 認証時期別 (推定) のパイプライン製品
  • 股関節再建 - 現在進行中の治験

第4章 股関節再建 - 開発中のパイプライン製品:企業別

  • 股関節再建企業 - 開発段階別のパイプライン製品
  • 股関節再建 - 開発段階別のパイプライン製品

第5章 股関節再建企業と製品の概要

  • Amedica Corporation
  • Bonovo Orthopedics, Inc.
  • Corentec Co., Ltd.
  • Corin Group Plc
  • DePuy Companies
  • Dimicron Inc.
  • Exactech, Inc.
  • Fortis Orthopedics
  • Fraunhofer Institute for Applied Polymer Research
  • Implants International Limited
  • INOR Orthopaedics
  • JRI Orthopaedics Ltd
  • 京セラメディカル
  • Limacorporate S.p.a.
  • MX Orthopedics, Corp.
  • Nano Interface Technology, Inc.
  • Naviswiss AG
  • OrthoGrid Systems
  • OrthoPediatrics Corp.
  • PLD Corporation Limited (Inactive)
  • PreSRV Ltd.
  • Renova Orthopedics, LLC
  • SAS HyPrevention
  • SINTEF
  • Stryker Corporation
  • Tech Manage Corp.
  • University of Alberta
  • University of South Florida
  • University of Warwick
  • Zimmer Biomet Holdings, Inc.

第6章 股関節再建 - 最近の動向

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0266EPD

GlobalData's Medical Devices sector report, "Hip Reconstruction - Medical Devices Pipeline Assessment, 2016" provides an overview of Hip Reconstruction currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hip Reconstruction pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hip Reconstruction under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hip Reconstruction and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hip Reconstruction under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Hip Reconstruction Overview

3 Products under Development

  • 3.1 Hip Reconstruction - Pipeline Products by Stage of Development
  • 3.2 Hip Reconstruction - Pipeline Products by Segment
  • 3.3 Hip Reconstruction - Pipeline Products by Territory
  • 3.4 Hip Reconstruction - Pipeline Products by Regulatory Path
  • 3.5 Hip Reconstruction - Pipeline Products by Estimated Approval Date
  • 3.6 Hip Reconstruction - Ongoing Clinical Trials

4 Hip Reconstruction - Pipeline Products under Development by Companies

  • 4.1 Hip Reconstruction Companies - Pipeline Products by Stage of Development
  • 4.2 Hip Reconstruction - Pipeline Products by Stage of Development

5 Hip Reconstruction Companies and Product Overview

  • 5.1 4-Web Spine, LLC Company Overview
    • 5.1.1 4-Web Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Amedica Corporation Company Overview
    • 5.2.1 Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Bonovo Orthopedics Inc Company Overview
    • 5.3.1 Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Corentec Co., Ltd. Company Overview
    • 5.4.1 Corentec Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 DePuy Synthes Inc Company Overview
    • 5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Exactech Inc Company Overview
    • 5.6.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Fortis Orthopedics Company Overview
    • 5.7.1 Fortis Orthopedics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Fraunhofer Institute for Applied Polymer Research Company Overview
    • 5.8.1 Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Implants International Limited Company Overview
    • 5.9.1 Implants International Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 INOR Orthopaedics Company Overview
    • 5.10.1 INOR Orthopaedics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 JRI Orthopaedics Ltd Company Overview
    • 5.11.1 JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 KYOCERA Medical Corp Company Overview
    • 5.12.1 KYOCERA Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Limacorporate S.p.a. Company Overview
    • 5.13.1 Limacorporate S.p.a. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 MicroPort Scientific Corporation Company Overview
    • 5.14.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 MX Orthopedics, Corp. Company Overview
    • 5.15.1 MX Orthopedics, Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Nano Interface Technology LLC (Inactive) Company Overview
    • 5.16.1 Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 OrthoGrid Systems Company Overview
    • 5.17.1 OrthoGrid Systems Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 PLD Corporation Limited (Inactive) Company Overview
    • 5.18.1 PLD Corporation Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 PreSRV Ltd. Company Overview
    • 5.19.1 PreSRV Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 Renova Orthopedics, LLC Company Overview
    • 5.20.1 Renova Orthopedics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Rochester Institute of Technology Company Overview
    • 5.21.1 Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 SINTEF Company Overview
    • 5.22.1 SINTEF Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Smith & Nephew Plc Company Overview
    • 5.23.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 Stryker Corporation Company Overview
    • 5.24.1 Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 University of Alberta Company Overview
    • 5.25.1 University of Alberta Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 University of Auckland Company Overview
    • 5.26.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 University of South Florida Company Overview
    • 5.27.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 University of Warwick Company Overview
    • 5.28.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Zimmer Biomet Holdings Inc Company Overview
    • 5.29.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Hip Reconstruction- Recent Developments

  • 6.1 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
  • 6.2 Nov 15, 2016: Henry Ford Radiation Oncology Receives 3-Year ACR Accreditation
  • 6.3 Nov 14, 2016: First-ever functional, patient-specific hip replacement procedures performed in the USA
  • 6.4 Nov 10, 2016: Amedica Reports Third Quarter 2016 Financial Results
  • 6.5 Nov 09, 2016: Corentec to Raise USD17.6 Million in Private Placement of Bonds Due 2021
  • 6.6 Nov 09, 2016: Materialise Reports Third Quarter 2016 Results
  • 6.7 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report
  • 6.8 Nov 02, 2016: Wright Medical Group Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance
  • 6.9 Nov 01, 2016: Intellijoint Surgical Raises USD8.2 Million in Series A Financing
  • 6.10 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results
  • 6.11 Oct 31, 2016: Exactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20.
  • 6.12 Oct 31, 2016: Orthofix International Reports Third Quarter 2016 Financial Results
  • 6.13 Oct 27, 2016: Stryker reports third quarter 2016 results
  • 6.14 Oct 21, 2016: Corin Orthopaedics Acquires Hip/Knee Business from Wright Medical for USD32.3 Million
  • 6.15 Oct 06, 2016: Amedica Provides Business Update
  • 6.16 Oct 05, 2016: Henry Ford Health System Announces New CEO of Health Alliance Plan
  • 6.17 Oct 05, 2016: Amedica Announces Workforce Reduction
  • 6.18 Sep 23, 2016: Implanet Announces Its 2016 First-Half Results: Buoyant Growth in Revenue and Substantial Gross Margin Improvement
  • 6.19 Sep 23, 2016: RMS Medical Products Posts Second Quarter 2017 Results
  • 6.20 Sep 20, 2016: Mount Carmel Health System announces Edward Lamb as new President and CEO
  • 6.21 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
  • 6.22 Sep 13, 2016: Orthogrid Systems Raises USD0.4 Million in Financing
  • 6.23 Aug 31, 2016: Tecomet May Sell Itself
  • 6.24 Aug 31, 2016: HealthTrust Awards University of Miami Health Care an Innovation Grant to Build 'Life Skills Gym' for Total Joint Replacement Patients
  • 6.25 Aug 25, 2016: Medtronic Reports First Quarter Financial Results
  • 6.26 Aug 25, 2016: Thammasat University Aims More Awards at the International Exhibition of Inventions of Geneva
  • 6.27 Aug 19, 2016: Amedica Announces Receipt of Nasdaq Notice of Bid Price Deficiency
  • 6.28 Aug 11, 2016: Amedica Reports Second Quarter 2016 Financial Results
  • 6.29 Aug 11, 2016: Materialise Reports Second Quarter 2016 Results
  • 6.30 Aug 02, 2016: Wright Medical Group Reports 2016 Second Quarter Financial Results and Increases 2016 Guidance
  • 6.31 Aug 01, 2016: JRI Orthopaedics Acquires Sheffield Medical Products
  • 6.32 Aug 01, 2016: Exactech Q2 Revenue Up 8% to $66.1 Million; Net Income up 20% to $4.4 Million; Diluted EPS $0.31 vs. $0.26
  • 6.33 Aug 01, 2016: Orthofix International Reports Second Quarter 2016 Financial Results
  • 6.34 Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results
  • 6.35 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results
  • 6.36 Jul 21, 2016: Stryker reports second quarter 2016 results
  • 6.37 Jul 18, 2016: Direct Anterior Approach for Hip Replacement now available at Frisbie
  • 6.38 Jul 12, 2016: Implanet: Q2 2016 Record Revenue of €2.1 Million with Spine Sales Growing by +68%
  • 6.39 Jul 11, 2016: CFO to leave Smith & Nephew in early 2017
  • 6.40 Jul 07, 2016: Study Launched to Evaluate Early Outcomes of Different Hip Replacement Techniques Using Portable Gait Analysis System
  • 6.41 Jul 05, 2016: United Orthopedic (UOC) Donates Orthopedic Replacement Systems to Hospital in China
  • 6.42 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
  • 6.43 Jun 29, 2016: New chairman appointed at JRI Orthopaedics
  • 6.44 Jun 17, 2016: New Study Reveals Hip Arthroscopy Effective Treatment For Hip Impingement: Outcome Varies Depending On Patient's Age And Sex
  • 6.45 Jun 14, 2016: EU ruling on medical devices
  • 6.46 Jun 13, 2016: Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares
  • 6.47 Jun 07, 2016: Corin's Optimized Positioning System (OPS) receives 510(k) clearance
  • 6.48 Jun 07, 2016: Zimmer Biomet Plans to Raise USD750 Million in Public Offering of Notes
  • 6.49 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day
  • 6.50 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
  • 6.51 May 23, 2016: Wright Medical to Raise Funds in Public Offering of Shares
  • 6.52 May 20, 2016: Amedica Raises USD12.7 Million in Public Offering of Units
  • 6.53 May 19, 2016: New Data and Milestones Back Medacta's Orthopedic Surgery Product Line Following 8th M.O.R.E. International Symposium
  • 6.54 May 19, 2016: Beijing Chunlizhengda Medical Instruments Announces Resignation And Appointment Of Chief Financial Officer
  • 6.55 May 13, 2016: Wright Medical to Raise USD395 Million in Private Placement of 2.25% Notes Due 2021
  • 6.56 May 12, 2016: Amedica Reports First Quarter 2016 Financial Results
  • 6.57 May 05, 2016: Smith & Nephew 2016 First Quarter Trading Report
  • 6.58 May 04, 2016: Wright Medical Group Reports 2016 First Quarter Financial Results and Increases 2016 Guidance
  • 6.59 Apr 28, 2016: Implanet: Q1 2016 revenues Strong increase in U.S. JAZZ sales: +106%
  • 6.60 Apr 28, 2016: Zimmer Biomet Holdings Reports First Quarter 2016 Financial Results
  • 6.61 Apr 28, 2016: Orthofix International Reports First Quarter 2016 Financial Results
  • 6.62 Apr 26, 2016: Exactech Q1 Revenue Up 6% to $65.3 Million. Net Income of $4.4 Million. Diluted EPS $0.31 vs. $0.29
  • 6.63 Apr 20, 2016: Stryker reports first quarter 2016 results
  • 6.64 Apr 18, 2016: Henry Ford Breast Cancer Program Granted 3-Year Accreditation
  • 6.65 Apr 13, 2016: Implanet Commences Trading on OTCQX in the U.S.
  • 6.66 Apr 12, 2016: Heard Robins Cloud Congratulates Plaintiffs for $500 Million Verdict in DePuy Hip Implant Trial
  • 6.67 Apr 05, 2016: Allegiance Health Joins Henry Ford Health System
  • 6.68 Mar 30, 2016: Implanet Announces 2015 Annual Results
  • 6.69 Mar 23, 2016: Amedica First to 3D Print Silicon Nitride for Medical Applications
  • 6.70 Mar 17, 2016: Simmons Hanly Conroy Announces Plaintiffs' $502 Million Bellwether Trial Verdict Against Johnson & Johnson over Faulty DePuy Pinnacle Hip Replacement Device
  • 6.71 Mar 17, 2016: Amedica Reports Fourth Quarter and Full Year 2015 Financial Results
  • 6.72 Mar 16, 2016: India Life Sciences Fund Invests in Biorad Medisys
  • 6.73 Mar 16, 2016: Intellijoint Surgical Enters into Distribution Agreement with Corin
  • 6.74 Mar 10, 2016: Humana Launches Value-Based Orthopedic Specialty Care Model in Ohio
  • 6.75 Mar 10, 2016: Exactech Announces Completion of Corporate Integrity Agreement Requirements
  • 6.76 Mar 04, 2016: Smith & Nephew : Annual Financial Report
  • 6.77 Mar 03, 2016: Stryker Raises USD750 Million in Public Offering of 2% Notes Due 2019
  • 6.78 Mar 03, 2016: Stryker Raises USD1 Billion in Public Offering of 4.625% Notes Due 2046
  • 6.79 Mar 03, 2016: Stryker Raises USD1 Billion in Public Offering of 3.5% Notes Due 2026
  • 6.80 Mar 03, 2016: Stryker Raises USD750 Million in Public Offering of 2.625% Notes Due 2021
  • 6.81 Mar 02, 2016: Zimmer Biomet Announces Commercial Launch of the Echo Bi-Metric Microplasty Stem
  • 6.82 Mar 02, 2016: Zimmer Biomet Announces Commercial Launch of the G7 Dual Mobility Construct
  • 6.83 Mar 02, 2016: Zimmer Biomet Announces Commercial Launch of the Arcos One-Piece Revision System
  • 6.84 Mar 01, 2016: Smith & Nephew unveils our first 3D-printed titanium hip implant
  • 6.85 Mar 01, 2016: Medacta Showcases Latest Surgical Innovation Mpact Acetabular System at American Academy of Orthopaedic Surgeons Annual Meeting
  • 6.86 Mar 01, 2016: CoorsTek Medical Announces FDA 510(k) Clearance for Total Hip System Incorporating CeraSurf-p Implantable Ceramic Components
  • 6.87 Mar 01, 2016: Exactech Innovations Simplify the Complexity of Revision Total Joint Replacement
  • 6.88 Feb 29, 2016: Orthofix International Reports Fourth Quarter and Fiscal 2015 Financial Results
  • 6.89 Feb 18, 2016: Amedica to Present 24-Month CASCADE Clinical Trial Results
  • 6.90 Feb 16, 2016: Exactech 2015 Revenue $241.8 Million, Net Income $14.8 Million, EPS $1.04
  • 6.91 Feb 09, 2016: Amedica Regains Compliance With Nasdaq Listing Requirements and Announces Capitalization Improvements
  • 6.92 Feb 04, 2016: Smith & Nephew Fourth Quarter Trading and Full Year 2015 Results
  • 6.93 Jan 28, 2016: Zimmer Biomet Holdings Reports Fourth Quarter and Full-Year 2015 Financial Results
  • 6.94 Jan 28, 2016: Amedica to Present Research Supporting Favorable Silicon Nitride Findings at the Orthopaedic Research Society Annual Meeting
  • 6.95 Jan 26, 2016: Stryker Reports 2015 Results and 2016 Outlook
  • 6.96 Jan 26, 2016: Stryker Announces the Retirement of William R. Jellison and the promotion of Glenn S. Boehnlein to Vice President, Chief Financial Officer
  • 6.97 Jan 26, 2016: IMPLANET announces results for the 4th quarter and full year to 31 December 2015
  • 6.98 Jan 19, 2016: OrthAlign Announces Upcoming Commercial Launch of OrthAlign Plus for Direct Anterior Total Hip Replacement
  • 6.99 Jan 12, 2016: Stryker Provides 2015 Preliminary Sales Results and Increases Adjusted Earnings Guidance
  • 6.100 Jan 12, 2016: Orthofix Announces Preliminary Fourth Quarter 2015 and Full Year Net Sales Results
  • 6.101 Jan 07, 2016: Intellijoint Surgical Receives FDA Clearance for the Next Generation of intellijoint HIP -- A Miniature Surgical Smart Tool for Cup Position, Leg Length, and Offset in Hip Replacement Surgery
  • 6.102 Dec 30, 2015: Amedica Signs International Private Label Supply Agreement With Chinese Orthopedic Company
  • 6.103 Dec 23, 2015: EQT to Acquire Limacorporate from Ardian
  • 6.104 Dec 16, 2015: HYPREVENTION Raised € 750,000 to Finance the Y-STRUT Product Launch, a Unique Medical Device to Prevent Hip Fracture
  • 6.105 Dec 16, 2015: Hyprevention Raises USD0.8 Million in Financing Round
  • 6.106 Dec 07, 2015: ulrich medical USA Settles Lawsuit against Amedica

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Table 1: Hip Reconstruction - Pipeline Products by Stage of Development
  • Table 2: Hip Reconstruction - Pipeline Products by Segment
  • Table 3: Hip Reconstruction - Pipeline Products by Territory
  • Table 4: Hip Reconstruction - Pipeline Products by Regulatory Path
  • Table 5: Hip Reconstruction - Pipeline Products by Estimated Approval Date
  • Table 6: Hip Reconstruction - Ongoing Clinical Trials
  • Table 7: Hip Reconstruction Companies - Pipeline Products by Stage of Development
  • Table 8: Hip Reconstruction - Pipeline Products by Stage of Development
  • Table 9: 4-Web Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Truss Implant - Hip Procedures - Product Status
  • Table 11: Truss Implant - Hip Procedures - Product Description
  • Table 12: Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Infinia Total Hip Implant II - Product Status
  • Table 14: Infinia Total Hip Implant II - Product Description
  • Table 15: Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: JMM Total Hip System - Product Status
  • Table 17: JMM Total Hip System - Product Description
  • Table 18: Konknow Hip System - Product Status
  • Table 19: Konknow Hip System - Product Description
  • Table 20: Corentec Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Bencox ID Cemented Stem - Collarless - Product Status
  • Table 22: Bencox ID Cemented Stem - Collarless - Product Description
  • Table 23: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Bone Preserving Hip Stem - Product Status
  • Table 25: Bone Preserving Hip Stem - Product Description
  • Table 26: DeltaMotion Hip System - Product Status
  • Table 27: DeltaMotion Hip System - Product Description
  • Table 28: Hip Resurfacing System - Product Status
  • Table 29: Hip Resurfacing System - Product Description
  • Table 30: New Poly Hip Bearing - Product Status
  • Table 31: New Poly Hip Bearing - Product Description
  • Table 32: Next Generation Hip System - Product Status
  • Table 33: Next Generation Hip System - Product Description
  • Table 34: DePuy Synthes Inc - Ongoing Clinical Trials Overview
  • Table 35: DeltaMotion Hip System - A Multi-center, Prospective, Uncontrolled Post Market Clinical Follow-up Study (PMCFS) to Monitor the Survival and Performance of the DeltaMotion Cup System in Subjects Requiring a Total Hip Replacement
  • Table 36: DeltaMotion Hip System - RSA-Measured in Vivo Migration and Micromotion in the DePuy Tri-lock, Corail and Deltamotion Hip Replacement Components: A Single-blinded Randomised Control Trial
  • Table 37: Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Alteon Acetabular System - Product Status
  • Table 39: Alteon Acetabular System - Product Description
  • Table 40: Alteon HA System - Product Status
  • Table 41: Alteon HA System - Product Description
  • Table 42: Alteon Revision Modular System - Product Status
  • Table 43: Alteon Revision Modular System - Product Description
  • Table 44: Exactech GPS Hip System - Product Status
  • Table 45: Exactech GPS Hip System - Product Description
  • Table 46: Hip Revision System - Product Status
  • Table 47: Hip Revision System - Product Description
  • Table 48: HIP Wedge Stem - Product Status
  • Table 49: HIP Wedge Stem - Product Description
  • Table 50: Fortis Orthopedics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: MiHip System - Product Status
  • Table 52: MiHip System - Product Description
  • Table 53: Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Enhanced Durability Resurfacing Endoprosthesis - Product Status
  • Table 55: Enhanced Durability Resurfacing Endoprosthesis - Product Description
  • Table 56: Implants International Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Phoenix Re-Surf - Product Status
  • Table 58: Phoenix Re-Surf - Product Description
  • Table 59: INOR Orthopaedics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK - Product Status
  • Table 61: INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK - Product Description
  • Table 62: INOR TOTAL HIP SYSTEM Stainless Steel XL Series-Long Neck - Product Status
  • Table 63: INOR TOTAL HIP SYSTEM Stainless Steel XL Series-Long Neck - Product Description
  • Table 64: JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Customised Hip Replacement Component - Product Status
  • Table 66: Customised Hip Replacement Component - Product Description
  • Table 67: KYOCERA Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: Aquala Liner - Product Status
  • Table 69: Aquala Liner - Product Description
  • Table 70: Limacorporate S.p.a. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: DELTA-ONE-TT - Product Status
  • Table 72: DELTA-ONE-TT - Product Description
  • Table 73: DELTA-Revision TT - Product Status
  • Table 74: DELTA-Revision TT - Product Description
  • Table 75: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: Anterior Approach THA Instrument - Product Status
  • Table 77: Anterior Approach THA Instrument - Product Description
  • Table 78: Next Generation Optimized ML Taper Hip Stem - Product Status
  • Table 79: Next Generation Optimized ML Taper Hip Stem - Product Description
  • Table 80: Total Hip Prosthesis - Product Status
  • Table 81: Total Hip Prosthesis - Product Description
  • Table 82: Universal Inline Broach Handle - Product Status
  • Table 83: Universal Inline Broach Handle - Product Description
  • Table 84: XL & E-POLY BIOFOAM - Product Status
  • Table 85: XL & E-POLY BIOFOAM - Product Description
  • Table 86: MX Orthopedics, Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: Shape Memory Alloy Hip Implant - Product Status
  • Table 88: Shape Memory Alloy Hip Implant - Product Description
  • Table 89: Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Hip Implant - Product Status
  • Table 91: Hip Implant - Product Description
  • Table 92: OrthoGrid Systems Pipeline Products & Ongoing Clinical Trials Overview
  • Table 93: HipFXGrid - Product Status
  • Table 94: HipFXGrid - Product Description
  • Table 95: PLD Corporation Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 96: M-COR Primary Press-Fit - Product Status
  • Table 97: M-COR Primary Press-Fit - Product Description
  • Table 98: PreSRV Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 99: Atlas Femoral Head Preserving Prosthesis - Product Status
  • Table 100: Atlas Femoral Head Preserving Prosthesis - Product Description
  • Table 101: Renova Orthopedics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 102: A-FX Hip Fracture System - Product Status
  • Table 103: A-FX Hip Fracture System - Product Description
  • Table 104: Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 105: Artificial Hip Joint - Product Status
  • Table 106: Artificial Hip Joint - Product Description
  • Table 107: SINTEF Pipeline Products & Ongoing Clinical Trials Overview
  • Table 108: Smart Hip Prosthesis - Product Status
  • Table 109: Smart Hip Prosthesis - Product Description
  • Table 110: Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 111: Navio Total Hip Arthroplasty System - Product Status
  • Table 112: Navio Total Hip Arthroplasty System - Product Description
  • Table 113: REDAPT Revision System - Product Status
  • Table 114: REDAPT Revision System - Product Description
  • Table 115: Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: Hip Distraction Device - Product Status
  • Table 117: Hip Distraction Device - Product Description
  • Table 118: MITCH TRH System - Product Status
  • Table 119: MITCH TRH System - Product Description
  • Table 120: University of Alberta Pipeline Products & Ongoing Clinical Trials Overview
  • Table 121: Hip Replacement And Bone Loss Monitor - Product Status
  • Table 122: Hip Replacement And Bone Loss Monitor - Product Description
  • Table 123: University of Auckland Pipeline Products & Ongoing Clinical Trials Overview
  • Table 124: Acetabular Reconstruction Implant - Product Status
  • Table 125: Acetabular Reconstruction Implant - Product Description
  • Table 126: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • Table 127: Cannulated Screw Jig - Product Status
  • Table 128: Cannulated Screw Jig - Product Description
  • Table 129: Injectable Hip Hemiarthroplasty Device - Product Status
  • Table 130: Injectable Hip Hemiarthroplasty Device - Product Description
  • Table 131: University of Warwick Pipeline Products & Ongoing Clinical Trials Overview
  • Table 132: Femoral Head Positioning Device - Product Status
  • Table 133: Femoral Head Positioning Device - Product Description
  • Table 134: Hip Prostheses - Product Status
  • Table 135: Hip Prostheses - Product Description
  • Table 136: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 137: Durom Full Resurfacing Hip - Product Status
  • Table 138: Durom Full Resurfacing Hip - Product Description
  • Table 139: E1 Avantage Hip Cup - Product Status
  • Table 140: E1 Avantage Hip Cup - Product Description
  • Table 141: ReCap Total Hip Resurfacing System - Product Status
  • Table 142: ReCap Total Hip Resurfacing System - Product Description
  • Table 143: Zimmer Biomet Holdings Inc - Ongoing Clinical Trials Overview
  • Table 144: E1 Avantage Hip Cup - Evaluation of Cemented and Cementless Fixation of Dual-mobility Hip Prosthesis in Elderly Patients With Osteoarthritis
  • Table 145: E1 Avantage Hip Cup - RCT of the Sirius Stem Used in Conjunction with the Exceed ABT Cemented Cup and OptiPac/OptiVac Cement - Model Based RSA, Clinical and Radiographic Outcomes
  • Table 146: Glossary

List of Figures

  • Figure 1: Hip Reconstruction - Pipeline Products by Stage of Development
  • Figure 2: Hip Reconstruction - Pipeline Products by Segment
  • Figure 3: Hip Reconstruction - Pipeline Products by Territory
  • Figure 4: Hip Reconstruction - Pipeline Products by Regulatory Path
  • Figure 5: Hip Reconstruction - Pipeline Products by Estimated Approval Date
  • Figure 6: Hip Reconstruction - Ongoing Clinical Trials
Back to Top